Comparative Study Between Only Vaginal Misoprostol and Vaginal Misoprostol and Estradiol Cream

Sponsor
Ain Shams University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05306405
Collaborator
(none)
120
1
2
6.3
19.1

Study Details

Study Description

Brief Summary

To compare the safety and effectiveness of vaginal misoprostol with combined vaginal misoprostol and estradiol for induction of labour in unfavorable cervix

Condition or Disease Intervention/Treatment Phase
  • Drug: Vaginal Tablet
Phase 1/Phase 2

Detailed Description

Induction of labour (IOL) is the process of initiating contractions of pregnant persons who are currently not in labour, to help them achieve vaginal delivery within 24 to 48 hours. Cervical ripening is one of the methods that used for labour induction; it is "the use of pharmacological or other means to soften, efface, or dilate the cervix to increase the likelihood of a vaginal delivery". The two major techniques for cervical ripening are mechanical interventions (e.g. insertion of balloon catheters), and application of pharmacological agents (e.g. prostaglandins). Prostaglandins are one of the preferred methods for cervical ripening, including the agents dinoprostone and misoprostol

. By the mid of-1980s prostaglandins had become established as the most effective pharmacological agents for inducing labour when the cervix is unripped. The vaginal route was found to be the most acceptable, providing good efficacy and acceptability for the parturient and it is the preferred choice now.

During the past 15 years the introduction of misoprostol, the prostaglandinsE1(PGE1) which, unlike prostglandinsE2 (PGE2), is stable at room temperature and it is effective if it was taken orally, has been the major focus of attention for labour induction. It is also considerably cheaper than the alternative prostaglandin.

With the ever-increasing concentrations of estrogen in the maternal circulation leading to term pregnancy, the belief that this could be a trigger for the onset of spontaneous labour led the studies to explore estrogens for the induction of labour.

Estradiol gel gives extra--amniotic, endocervical or vaginally or estradiol intramuscularly and estradiol gel extra-amniotic have been shown to produce some improved cervical favorability with minimal myometrial stimulation.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
120 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Comparative Study Between Using Only Vaginal Misoprostol and Using Vaginal Misoprostol and Estradiol Cream for Induction of Labour
Actual Study Start Date :
Feb 20, 2022
Anticipated Primary Completion Date :
Aug 1, 2022
Anticipated Study Completion Date :
Aug 30, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: vaginal misoprostol

only vaginal misoprostol 25 μg tablets will be applied for induction of laour

Drug: Vaginal Tablet
Misoprostol alone will be repeated every 4 h in both groups for a maximum of 5 doses, reaching Bishop score >8, rupture of membranes or occurrence of labor pain. Cervical evaluation will be done using Bishop's score. A score < 5 will be taken as unfavorable Cervix will be termed as ripped when Bishop's score equal 8 or more. The endpoint of the study will be initiation of active phase of 1st stage of labor which commence from 6cm to full cervical dilatation
Other Names:
  • vaginal misoprostol and vaginal estradiol
  • Active Comparator: combined vaginal misoprostol and estradiol

    vaginal misoprostol 25 μg (Vagiprost) tablets with vaginal estradiol 150 ml cream will be applied for induction of laour

    Drug: Vaginal Tablet
    Misoprostol alone will be repeated every 4 h in both groups for a maximum of 5 doses, reaching Bishop score >8, rupture of membranes or occurrence of labor pain. Cervical evaluation will be done using Bishop's score. A score < 5 will be taken as unfavorable Cervix will be termed as ripped when Bishop's score equal 8 or more. The endpoint of the study will be initiation of active phase of 1st stage of labor which commence from 6cm to full cervical dilatation
    Other Names:
  • vaginal misoprostol and vaginal estradiol
  • Outcome Measures

    Primary Outcome Measures

    1. Induction of labour with closed cervix [from 0 hours to 14 hours after induction of labour]

      assessment of uterine contractions and cervical opening of the pregnant females who are currently not in labour, to help them to reach normal vaginal delivery process.

    Secondary Outcome Measures

    1. The Whole Delivery time after induction of labour. [from 0 hours to the end of the delivery]

      The whole time from induction to the end of vaginal labour with complications that may arise as: -uterine hyperstimulation, postpartum hemorrhage, rupture of the uterus and neonatal morbidity, fetal distress, and fetal hypoxia.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    20 Years to 39 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Gestational age36:41 weeks.

    • Singleton pregnancy.

    • Absence of labour pain.

    • Living fetus with cephalic presentation.

    • Fetal weight < 4 k.gs.

    • No previous uterine surgical procedures.

    • No liquor abnormalities.

    • Bishop score < 5.

    Exclusion Criteria:
      • Multiple gestations. one of the contraindications of induction of labor as it may cause rupture of the uterus.
    • Liquor abnormalities.one of contraindications of induction of labor as it may cause fetal distress.

    • Abnormal umbilical artery Doppler indices or non-stress test as these indicate fetal distress.

    • Fetal weight > 4 kgs.as macrosomia is an indication of caesarean section for fear of shoulder dystocia .

    • Previous uterine surgery.contraindication of labor induction for fear of rupture uterus.

    • Asthmatic patient or women with allergy to prostaglandins or steroidal.

    • Non-vertex presentation.contraindication of labor induction as it may cause rupture uterus.

    • Fetal or maternal complications that might cause cesarean section.

    • Intrauterine fetal death.often induction of labor in women with a dead fetus is performed before term when the uterus may be less responsive to uterotonics than it is at term and this will affect the results of the study

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Ain Shams University Cairo Egypt

    Sponsors and Collaborators

    • Ain Shams University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Amira Maher, Resident of Obstetrics and Gynecology at Al-Delengat General Hospital, Ain Shams University
    ClinicalTrials.gov Identifier:
    NCT05306405
    Other Study ID Numbers:
    • 001
    First Posted:
    Apr 1, 2022
    Last Update Posted:
    Apr 1, 2022
    Last Verified:
    Mar 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Amira Maher, Resident of Obstetrics and Gynecology at Al-Delengat General Hospital, Ain Shams University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 1, 2022